|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 114, Issue 8 1483-1489, Copyright © 2001 by Company of Biologists
JOURNAL ARTICLES |
H Aoki, M Fujii, T Imamura, K Yagi, K Takehara, M Kato and K Miyazono
Dept of Biochemistry, The JFCR Cancer Institute, and Research for the Future Program, the Japan Society for the Promotion of Science, Toshima-ku, Tokyo 170-8455, Japan. miyazono-ind@umin.ac.jp
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-(&bgr;) superfamily, which regulate the differentiation of osteoprogenitor cells. Here we show that among members of the BMP family, BMP-4 and growth/differentiation factor 5 (GDF-5) induce osteoblast differentiation through the activation of three receptor-regulated Smads (i.e. Smad1, Smad5 and Smad8). By contrast, BMP-6 and BMP-7 induce alkaline phosphatase activity through Smad1 and Smad5, but not through Smad8. Consistent with these findings, BMP-4 induced phosphorylation and nuclear translocation of Smad1, Smad5 and Smad8, but BMP-6 activated only Smad1 and Smad5. BMP-4 and GDF-5 are known to bind to activin receptor-like kinase 3 (ALK-3) and/or ALK-6 (also termed BMP type IA and type IB receptors, respectively), whereas BMP-6 and BMP-7 preferentially bind to ALK-2. Compared with the effects induced by only one of the type I receptors, the combination of constitutively active forms of ALK-2 and ALK-3 (or ALK-6) more strongly induced alkaline phosphatase activity in C2C12 cells. Moreover, addition of BMP-4 and BMP-6 to C2C12 cells resulted in higher alkaline phosphatase activity than that of only one of these BMPs. The combination of ALK-2 and ALK-3 also induced higher transcriptional activity than either receptor alone. Thus, ALK-2 and ALK-3 (or ALK-6) might synergistically induce osteoblast differentiation of C2C12 cells, possibly through efficient activation of downstream signaling pathways.
This article has been cited by other articles:
![]() |
J.T. Koh, Z. Zhao, Z. Wang, I.S. Lewis, P.H. Krebsbach, and R.T. Franceschi Combinatorial Gene Therapy with BMP2/7 Enhances Cranial Bone Regeneration J. Dent. Res., September 1, 2008; 87(9): 845 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lavery, P. Swain, D. Falb, and M. H. Alaoui-Ismaili BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells J. Biol. Chem., July 25, 2008; 283(30): 20948 - 20958. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyoshi, F. Otsuka, H. Otani, K. Inagaki, J. Goto, M. Yamashita, T. Ogura, Y. Iwasaki, and H. Makino Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells J. Endocrinol., April 1, 2008; 197(1): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Upton, L. Long, R. C. Trembath, and N. W. Morrell Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells Mol. Pharmacol., February 1, 2008; 73(2): 539 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wordinger and A. F. Clark Bone Morphogenetic Proteins and Their Receptors in the Eye Experimental Biology and Medicine, September 1, 2007; 232(8): 979 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Goto, Y. Kamiya, T. Imamura, K. Miyazono, and K. Miyazawa Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors J. Biol. Chem., July 13, 2007; 282(28): 20603 - 20611. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-beta1 and BMP-7 Signaling J. Biol. Chem., May 11, 2007; 282(19): 13934 - 13943. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B Lee, V. Khivansara, M. M Santos, P. Lamba, T. Yuen, S. C Sealfon, and D. J Bernard Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone {beta} subunit transcription J. Mol. Endocrinol., February 1, 2007; 38(2): 315 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyoshi, F. Otsuka, K. Inagaki, H. Otani, M. Takeda, J. Suzuki, J. Goto, T. Ogura, and H. Makino Differential Regulation of Steroidogenesis by Bone Morphogenetic Proteins in Granulosa Cells: Involvement of Extracellularly Regulated Kinase Signaling and Oocyte Actions in Follicle-Stimulating Hormone-Induced Estrogen Production Endocrinology, January 1, 2007; 148(1): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inagaki, F. Otsuka, J. Suzuki, Y. Kano, M. Takeda, T. Miyoshi, H. Otani, Y. Mimura, T. Ogura, and H. Makino Involvement of Bone Morphogenetic Protein-6 in Differential Regulation of Aldosterone Production by Angiotensin II and Potassium in Human Adrenocortical Cells Endocrinology, June 1, 2006; 147(6): 2681 - 2689. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyoshi, F. Otsuka, J. Suzuki, M. Takeda, K. Inagaki, Y. Kano, H. Otani, Y. Mimura, T. Ogura, and H. Makino Mutual Regulation of Follicle-Stimulating Hormone Signaling and Bone Morphogenetic Protein System in Human Granulosa Cells Biol Reprod, June 1, 2006; 74(6): 1073 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C Jayawardana, T. Shimizu, H. Nishimoto, E. Kaneko, M. Tetsuka, and A. Miyamoto Hormonal regulation of expression of growth differentiation factor-9 receptor type I and II genes in the bovine ovarian follicle. Reproduction, March 1, 2006; 131(3): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Yew, M. Hembree, K. Prasadan, B. Preuett, C. McFall, C. Benjes, A. Crowley, S. Sharp, S. Tulachan, S. Mehta, et al. Cross-talk between Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling Is Essential for Exendin-4-induced Insulin-positive Differentiation of AR42J Cells J. Biol. Chem., September 16, 2005; 280(37): 32209 - 32217. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Yoon, D. A. Ovchinnikov, I. Yoshii, Y. Mishina, R. R. Behringer, and K. M. Lyons Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo PNAS, April 5, 2005; 102(14): 5062 - 5067. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Juengel and K.P. McNatty The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development Hum. Reprod. Update, March 1, 2005; 11(2): 144 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki, D. Miura, H. Fujio, H. Matsubara, H. Date, T. Ohe, et al. Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action Endocrinology, September 1, 2004; 145(9): 4344 - 4354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brederlau, R. Faigle, M. Elmi, A. Zarebski, S. Sjoberg, M. Fujii, K. Miyazono, and K. Funa The Bone Morphogenetic Protein Type Ib Receptor Is a Major Mediator of Glial Differentiation and Cell Survival in Adult Hippocampal Progenitor Cell Culture Mol. Biol. Cell, August 1, 2004; 15(8): 3863 - 3875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson The Bone Morphogenetic Protein System In Mammalian Reproduction Endocr. Rev., February 1, 2004; 25(1): 72 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells Endocrinology, February 1, 2004; 145(2): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hay, J. Lemonnier, O. Fromigue, H. Guenou, and P. J. Marie Bone Morphogenetic Protein Receptor IB Signaling Mediates Apoptosis Independently of Differentiation in Osteoblastic Cells J. Biol. Chem., January 16, 2004; 279(3): 1650 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-X. Ying, Z. J. Hussain, and Y. E. Zhang Smurf1 Facilitates Myogenic Differentiation and Antagonizes the Bone Morphogenetic Protein-2-induced Osteoblast Conversion by Targeting Smad5 for Degradation J. Biol. Chem., October 3, 2003; 278(40): 39029 - 39036. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hatakeyama, J. Nguyen, X. Wang, G. H. Nuckolls, and L. Shum Smad Signaling in Mesenchymal and Chondroprogenitor Cells J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canalis, A. N. Economides, and E. Gazzerro Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton Endocr. Rev., April 1, 2003; 24(2): 218 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Moore, F. Otsuka, and S. Shimasaki Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells J. Biol. Chem., January 3, 2003; 278(1): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Raju, N. Dimova, P. S. Klein, and H.-C. Huang SANE, a Novel LEM Domain Protein, Regulates Bone Morphogenetic Protein Signaling through Interaction with Smad1 J. Biol. Chem., January 3, 2003; 278(1): 428 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Skillington, L. Choy, and R. Derynck Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes J. Cell Biol., October 14, 2002; 159(1): 135 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Valcourt, J. Gouttenoire, A. Moustakas, D. Herbage, and F. Mallein-Gerin Functions of Transforming Growth Factor-beta Family Type I Receptors and Smad Proteins in the Hypertrophic Maturation and Osteoblastic Differentiation of Chondrocytes J. Biol. Chem., September 6, 2002; 277(37): 33545 - 33558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishihara, T. Watabe, T. Imamura, and K. Miyazono Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary Hypertension Mol. Biol. Cell, September 1, 2002; 13(9): 3055 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gaussin, T. Van de Putte, Y. Mishina, M. C. Hanks, A. Zwijsen, D. Huylebroeck, R. R. Behringer, and M. D. Schneider Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3 PNAS, February 14, 2002; (2002) 42390499. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gaussin, T. Van de Putte, Y. Mishina, M. C. Hanks, A. Zwijsen, D. Huylebroeck, R. R. Behringer, and M. D. Schneider Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3 PNAS, March 5, 2002; 99(5): 2878 - 2883. [Abstract] [Full Text] [PDF] |
||||